1268 related articles for article (PubMed ID: 32571934)
21. Age-Dependent Progression of SARS-CoV-2 Infection in Syrian Hamsters.
Osterrieder N; Bertzbach LD; Dietert K; Abdelgawad A; Vladimirova D; Kunec D; Hoffmann D; Beer M; Gruber AD; Trimpert J
Viruses; 2020 Jul; 12(7):. PubMed ID: 32698441
[TBL] [Abstract][Full Text] [Related]
22. Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters.
Roberts A; Vogel L; Guarner J; Hayes N; Murphy B; Zaki S; Subbarao K
J Virol; 2005 Jan; 79(1):503-11. PubMed ID: 15596843
[TBL] [Abstract][Full Text] [Related]
23. Functional mapping of B-cell linear epitopes of SARS-CoV-2 in COVID-19 convalescent population.
Yi Z; Ling Y; Zhang X; Chen J; Hu K; Wang Y; Song W; Ying T; Zhang R; Lu H; Yuan Z
Emerg Microbes Infect; 2020 Dec; 9(1):1988-1996. PubMed ID: 32844713
[No Abstract] [Full Text] [Related]
24. Co-administration of Favipiravir and the Remdesivir Metabolite GS-441524 Effectively Reduces SARS-CoV-2 Replication in the Lungs of the Syrian Hamster Model.
Chiba S; Kiso M; Nakajima N; Iida S; Maemura T; Kuroda M; Sato Y; Ito M; Okuda M; Yamada S; Iwatsuki-Horimoto K; Watanabe T; Imai M; Armbrust T; Baric RS; Halfmann PJ; Suzuki T; Kawaoka Y
mBio; 2021 Feb; 13(1):e0304421. PubMed ID: 35100870
[TBL] [Abstract][Full Text] [Related]
25. SARS-CoV-2 infection protects against rechallenge in rhesus macaques.
Chandrashekar A; Liu J; Martinot AJ; McMahan K; Mercado NB; Peter L; Tostanoski LH; Yu J; Maliga Z; Nekorchuk M; Busman-Sahay K; Terry M; Wrijil LM; Ducat S; Martinez DR; Atyeo C; Fischinger S; Burke JS; Slein MD; Pessaint L; Van Ry A; Greenhouse J; Taylor T; Blade K; Cook A; Finneyfrock B; Brown R; Teow E; Velasco J; Zahn R; Wegmann F; Abbink P; Bondzie EA; Dagotto G; Gebre MS; He X; Jacob-Dolan C; Kordana N; Li Z; Lifton MA; Mahrokhian SH; Maxfield LF; Nityanandam R; Nkolola JP; Schmidt AG; Miller AD; Baric RS; Alter G; Sorger PK; Estes JD; Andersen H; Lewis MG; Barouch DH
Science; 2020 Aug; 369(6505):812-817. PubMed ID: 32434946
[TBL] [Abstract][Full Text] [Related]
26. Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity.
Kaptein SJF; Jacobs S; Langendries L; Seldeslachts L; Ter Horst S; Liesenborghs L; Hens B; Vergote V; Heylen E; Barthelemy K; Maas E; De Keyzer C; Bervoets L; Rymenants J; Van Buyten T; Zhang X; Abdelnabi R; Pang J; Williams R; Thibaut HJ; Dallmeier K; Boudewijns R; Wouters J; Augustijns P; Verougstraete N; Cawthorne C; Breuer J; Solas C; Weynand B; Annaert P; Spriet I; Vande Velde G; Neyts J; Rocha-Pereira J; Delang L
Proc Natl Acad Sci U S A; 2020 Oct; 117(43):26955-26965. PubMed ID: 33037151
[TBL] [Abstract][Full Text] [Related]
27. Pathogenic and transcriptomic differences of emerging SARS-CoV-2 variants in the Syrian golden hamster model.
O'Donnell KL; Pinski AN; Clancy CS; Gourdine T; Shifflett K; Fletcher P; Messaoudi I; Marzi A
EBioMedicine; 2021 Nov; 73():103675. PubMed ID: 34758415
[TBL] [Abstract][Full Text] [Related]
28. A Replication-Competent Vesicular Stomatitis Virus for Studies of SARS-CoV-2 Spike-Mediated Cell Entry and Its Inhibition.
Dieterle ME; Haslwanter D; Bortz RH; Wirchnianski AS; Lasso G; Vergnolle O; Abbasi SA; Fels JM; Laudermilch E; Florez C; Mengotto A; Kimmel D; Malonis RJ; Georgiev G; Quiroz J; Barnhill J; Pirofski LA; Daily JP; Dye JM; Lai JR; Herbert AS; Chandran K; Jangra RK
Cell Host Microbe; 2020 Sep; 28(3):486-496.e6. PubMed ID: 32738193
[TBL] [Abstract][Full Text] [Related]
29. Attenuated SARS-CoV-2 variants with deletions at the S1/S2 junction.
Lau SY; Wang P; Mok BW; Zhang AJ; Chu H; Lee AC; Deng S; Chen P; Chan KH; Song W; Chen Z; To KK; Chan JF; Yuen KY; Chen H
Emerg Microbes Infect; 2020 Dec; 9(1):837-842. PubMed ID: 32301390
[TBL] [Abstract][Full Text] [Related]
30. [Specific features of the pathology of the respiratory system in SARS-CoV-2 (Coronaviridae: Coronavirinae: Betacoronavirus: Sarbecovirus) infected Syrian hamsters (Mesocricetus auratus)].
Chepur SV; Alekseeva II; Vladimirova OO; Myasnikov VA; Tyunin MA; Ilinskii NS; Nikishin AS; Shevchenko VA; Smirnova AV
Vopr Virusol; 2022 Jan; 66(6):442-451. PubMed ID: 35019251
[TBL] [Abstract][Full Text] [Related]
31. Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection.
Rosenke K; Meade-White K; Letko M; Clancy C; Hansen F; Liu Y; Okumura A; Tang-Huau TL; Li R; Saturday G; Feldmann F; Scott D; Wang Z; Munster V; Jarvis MA; Feldmann H
Emerg Microbes Infect; 2020 Dec; 9(1):2673-2684. PubMed ID: 33251966
[TBL] [Abstract][Full Text] [Related]
32. The G614 pandemic SARS-CoV-2 variant is not more pathogenic than the original D614 form in adult Syrian hamsters.
Stauft CB; Lien CZ; Selvaraj P; Liu S; Wang TT
Virology; 2021 Apr; 556():96-100. PubMed ID: 33556653
[TBL] [Abstract][Full Text] [Related]
33. Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model.
Rockx B; Kuiken T; Herfst S; Bestebroer T; Lamers MM; Oude Munnink BB; de Meulder D; van Amerongen G; van den Brand J; Okba NMA; Schipper D; van Run P; Leijten L; Sikkema R; Verschoor E; Verstrepen B; Bogers W; Langermans J; Drosten C; Fentener van Vlissingen M; Fouchier R; de Swart R; Koopmans M; Haagmans BL
Science; 2020 May; 368(6494):1012-1015. PubMed ID: 32303590
[TBL] [Abstract][Full Text] [Related]
34. Vaccine-Boosted CCP Decreases Virus Replication and Hastens Resolution of Infection Despite Transiently Enhancing Disease in SARS-CoV-2-Infected Hamsters.
Carroll TD; Wong T; Morris MK; Di Germanio C; Ma ZM; Stone M; Ball E; Fritts L; Rustagi A; Simmons G; Busch M; Miller CJ
J Infect Dis; 2024 Jun; 229(6):1702-1710. PubMed ID: 38213276
[TBL] [Abstract][Full Text] [Related]
35. Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing Strategy.
Du S; Cao Y; Zhu Q; Yu P; Qi F; Wang G; Du X; Bao L; Deng W; Zhu H; Liu J; Nie J; Zheng Y; Liang H; Liu R; Gong S; Xu H; Yisimayi A; Lv Q; Wang B; He R; Han Y; Zhao W; Bai Y; Qu Y; Gao X; Ji C; Wang Q; Gao N; Huang W; Wang Y; Xie XS; Su XD; Xiao J; Qin C
Cell; 2020 Nov; 183(4):1013-1023.e13. PubMed ID: 32970990
[TBL] [Abstract][Full Text] [Related]
36. Dynamic Changes of the Blood Chemistry in Syrian Hamsters Post-Acute COVID-19.
Hsu CJ; Lin WC; Chou YC; Yang CM; Wu HL; Cheng YH; Liu PC; Chang JY; Chen HY; Sun JR
Microbiol Spectr; 2022 Feb; 10(1):e0236221. PubMed ID: 35196799
[TBL] [Abstract][Full Text] [Related]
37. Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian hamsters.
Roberts A; Thomas WD; Guarner J; Lamirande EW; Babcock GJ; Greenough TC; Vogel L; Hayes N; Sullivan JL; Zaki S; Subbarao K; Ambrosino DM
J Infect Dis; 2006 Mar; 193(5):685-92. PubMed ID: 16453264
[TBL] [Abstract][Full Text] [Related]
38. Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets.
Park SJ; Yu KM; Kim YI; Kim SM; Kim EH; Kim SG; Kim EJ; Casel MAB; Rollon R; Jang SG; Lee MH; Chang JH; Song MS; Jeong HW; Choi Y; Chen W; Shin WJ; Jung JU; Choi YK
mBio; 2020 May; 11(3):. PubMed ID: 32444382
[TBL] [Abstract][Full Text] [Related]
39. Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and Transmissibility.
Chan JF; Zhang AJ; Yuan S; Poon VK; Chan CC; Lee AC; Chan WM; Fan Z; Tsoi HW; Wen L; Liang R; Cao J; Chen Y; Tang K; Luo C; Cai JP; Kok KH; Chu H; Chan KH; Sridhar S; Chen Z; Chen H; To KK; Yuen KY
Clin Infect Dis; 2020 Dec; 71(9):2428-2446. PubMed ID: 32215622
[TBL] [Abstract][Full Text] [Related]
40. SARS-CoV-2 Variant Pathogenesis Following Primary Infection and Reinfection in Syrian Hamsters.
Plunkard J; Mulka K; Zhou R; Tarwater P; Zhong W; Lowman M; Wong A; Pekosz A; Villano J
mBio; 2023 Apr; 14(2):e0007823. PubMed ID: 37036339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
